| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf4b14f3072db57d45fbf0b99e144740
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb7ce8745175865c6357f7d5fe7fccf5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3db7923b8399b8e052eecd89c2dd551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16bbdf8d6d0741262911d51e5c9fee7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40da09681f3bd00bc88a58d1dfd51897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41b3fb150c337d092eb3a3af6d8fefdb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_885cfdb9f042241b5f731e23f41b7f3f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2011-01-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45a54b80098d34ce170ad881d9074601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481fbf9bba60dbb02801d2f7e1fe67c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef5da0aab86520cd068477bbeba3e7dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b72f0b9c36dda61edce88d2eca84923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c4f88a471e7ee437a3199f801d25259
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d846687ab22e1499b123ac8fdf9bd1be |
| publicationDate |
2011-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011087926-A1 |
| titleOfInvention |
A CUT-POINT IN PTEN PROTEIN EXPRESSION THAT ACCURATELY IDENTIFIES TUMORS AND IS PREDICTIVE OF DRUG RESPONSE TO A PAN-ErbB INHIBITOR |
| abstract |
A cut-point in the quantitative measurement of PTEN protein expression that accurately identifies tumors with two inactivated alleles of the PTEN gene. Patients with a normalized PTEN score of PTEN null will be treated with a pan-ErbB tyrosine kinase inhibitor. A normalized PTEN protein expression score is obtained by comparing the tumor PTEN OD expression value with the non-malignant PTEN OD expression value. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10094834-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015529823-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104010494-A |
| priorityDate |
2010-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |